STOCK TITAN

Innerscope Hear Stock Price, News & Analysis

INND OTC

Welcome to our dedicated page for Innerscope Hear news (Ticker: INND), a resource for investors and traders seeking the latest updates and insights on Innerscope Hear stock.

InnerScope Hearing Technologies Inc. (OTC: INND) generates news around the Over-the-Counter (OTC) hearing aid and digital health markets. Company announcements highlight its activities as a manufacturer and distributor of OTC hearing aids, hearing aid accessories, and hearing health-related products, as well as its efforts to expand access to affordable hearing solutions through major retailers and pharmacy chains.

News coverage frequently focuses on wholesale distribution milestones, such as the launch of HearingAssist branded OTC rechargeable hearing aids on Target.com, Walgreens.com, and CVS.com, and the placement of products in selected pharmacy locations and vision centers. Releases also describe the deployment of hearing screening kiosks in pharmacies and the rollout of online hearing screening tools on retailer websites.

Another recurring theme in InnerScope’s news is corporate development and partnerships. The company has reported acquisitions of iHear Medical Inc. and HearingAssist, gaining patents, an R&D facility, and an established customer base. It has also announced a partnership with Atlazo Inc. for next-generation AI smart devices and a strategic alliance related to the pending acquisition of OTCHealth Inc. by Ainnova Tech Inc., in which InnerScope is an equity owner.

Investors and observers can also find updates on financial performance and strategy, including prior-year financial results, commentary on the impact of the U.S. OTC hearing aid regulatory framework, and the company’s shift toward a B2B wholesale distribution model. Additional news items cover investor relations initiatives, such as the engagement of external investor relations firms and plans related to financial audits and reporting status.

For those following INND, this news stream provides context on product launches, distribution agreements, technology partnerships, and strategic transactions that shape InnerScope’s role in the OTC hearing aid and hearing health markets.

Rhea-AI Summary

InnerScope Hearing Technologies (OTC: INND) announced a strategic alliance tied to Ainnova Tech's pending acquisition of OTCHealth on October 22, 2025. InnerScope will transition the majority of its day-to-day sales operations and its retail agreements with Walmart, CVS, Target, Walgreens and a network representing 15,000+ independent pharmacies to OTCHealth as a new Ainnova subsidiary.

InnerScope will receive equity and profit participation in OTCHealth and Ainnova post-acquisition, while refocusing on global R&D and hearing-technology integration with Ainnova's AI diagnostics and upcoming retinal camera to support earlier detection of vascular, neurological, and hearing-related conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
partnership acquisition
-
Rhea-AI Summary

InnerScope Hearing Technologies (OTC: INND) has announced the launch of OTCHealthMart.com, a new online platform offering affordable health and wellness products. The e-commerce site features OTC hearing aids under HearingAssist and iHEAR brands, along with vitamins and health supplements specifically designed for the 55+ demographic.

The platform offers grand opening promotions including discounted pricing on bestselling products and free shipping on orders over $75. The company plans to expand its product line to include durable medical equipment (DME) in its next phase. The website aims to provide expert-curated products, competitive pricing, and educational resources to support customers' health journeys.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
27.27%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
25%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.11%
Tags
none
-
Rhea-AI Summary

InnerScope Hearing Technologies (OTC: INND) has launched its HearingAssist brand of FDA-Registered OTC Rechargeable Hearing Aids on Walgreens.com. This strategic move is part of InnerScope's B2B sales growth strategy, allowing them to reach millions of Walgreens customers. The HearingAssist Rechargeable OTC Hearing Aids, priced between $499 and $799, promise affordability and high-quality features, including Bluetooth connectivity. With over 500,000 hearing aids sold, InnerScope aims to dominate the OTC market by enhancing access to effective hearing solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.57%
Tags
none
Rhea-AI Summary

InnerScope Hearing Technologies (OTC: INND) has launched its HearingAssist brand of FDA-registered Over-the-Counter (OTC) rechargeable hearing aids on Walgreens.com, expanding its market reach. This launch grants nationwide access to consumers seeking affordable hearing solutions, with prices ranging from $499 to $799 per pair. InnerScope claims to be America's #1 OTC hearing aid brand, having sold over 500,000 units. The new hearing aids feature advanced technology such as Bluetooth connectivity, enabling users to stream audio from smartphones. InnerScope's strategy focuses on increasing B2B sales through major retailers, positioning itself as a leader in the OTC hearing aid market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.57%
Tags
none
-
Rhea-AI Summary

InnerScope Hearing Technologies (OTC: INND) reported a profitable year-end 2022, highlighting consolidated net revenues of $15,284,327, gross profit of $9,079,335, and a net profit of $5,575,892. The company's EBITA stood at 36%, demonstrating strong operational efficiency. Driven by wholesale distribution agreements from its acquisitions of HearingAssist and iHEAR, InnerScope expanded its market presence significantly. In line with the FDA ruling enabling OTC hearing aids' sale without a prescription, InnerScope pivoted to a B2B model, enhancing its retail partnerships. The annual financial report is available on OTC Markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.11%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

InnerScope Hearing Technologies (OTC: INND) has announced the launch of its HearingAssist brand of FDA-Registered Over-the-Counter (OTC) Rechargeable Hearing Aids on Target.com. This expansion aims to reach nearly 30 million Americans in need of hearing solutions. The HearingAssist devices are priced between $499 and $599, featuring Bluetooth technology and advanced sound enhancement capabilities. With over 500,000 hearing aids sold, InnerScope is positioned as a leader in the affordable OTC hearing aid market, benefitting from the recent OTC Hearing Aid Law. The launch on Target strengthens its market distribution through major retailers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.65%
Tags

FAQ

What is the current stock price of Innerscope Hear (INND)?

The current stock price of Innerscope Hear (INND) is $0.0009 as of February 6, 2026.

What is the market cap of Innerscope Hear (INND)?

The market cap of Innerscope Hear (INND) is approximately 146.9K.
Innerscope Hear

OTC:INND

INND Rankings

INND Stock Data

146.87k
91.51M
2.81%
Medical Instruments & Supplies
Healthcare
Link
United States
Roseville

INND RSS Feed